L 2 to
7 days after administration of contrast material. Patients
with renal disease (eGFR # 45 mL/min/1.73 m2), diabetes,
congestive heart failure, ejection fraction <40%, hypertension, anemia, advanced age, proteinuria, and gout
are at increased risk for CIN.130 Gadolinium is not a safe
alternative to iodinated contrast agents, given the risk
for nephrogenic